blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1494711

EP1494711 - METHODS FOR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  12.06.2009
Database last updated on 03.10.2024
Most recent event   Tooltip12.06.2009Application deemed to be withdrawnpublished on 15.07.2009  [2009/29]
Applicant(s)For all designated states
Abgenix, Inc.
6701 Kaiser Drive
Fremont, CA 94555 / US
For all designated states
Pfizer Inc.
235 East 42nd Street
New York, NY 10017 / US
[N/P]
Former [2005/02]For all designated states
Abgenix, Inc.
6701 Kaiser Drive
Fremont, CA 94555 / US
For all designated states
PFIZER INC.
235 East 42nd Street
New York, N.Y. 10017 / US
Inventor(s)01 / YANG, Xiao-dong
2833 Bryant Street
Palo Alto, CA 94306 / US
02 / BELL, Gregory, M.
157 Trinidad Drive
Tiburon, CA 94920 / US
03 / GLADUE, Ronald, P.
83 Rowley Drive
Stonington, CT 06378 / US
04 / KUDLACZ, Elizabeth, M.
24 Thomas Road
Groton, CT 06340 / US
05 / SHOWELL, Henry, J.
231 Seaside Avenue
Westbrook, CT 06498 / US
 [2005/02]
Representative(s)Brants, Johan P.E., et al
De Clercq, Brants & Partners cv
Edgard Gevaertdreef 10a
9830 Sint-Martens-Latem / BE
[N/P]
Former [2005/02]Brants, Johan Philippe Emile, et al
De Clercq, Brants & Partners cv Edgard Gevaertdreef 10a
9830 Sint-Martens-Latem / BE
Application number, filing date03716745.918.03.2003
[2005/02]
WO2003US08662
Priority number, dateUS20020366426P19.03.2002         Original published format: US 366426 P
[2005/02]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO03080117
Date:02.10.2003
Language:EN
[2003/40]
Type: A1 Application with search report 
No.:EP1494711
Date:12.01.2005
Language:EN
The application published by WIPO in one of the EPO official languages on 02.10.2003 takes the place of the publication of the European patent application.
[2005/02]
Search report(s)International search report - published on:US02.10.2003
(Supplementary) European search report - dispatched on:EP29.04.2008
ClassificationIPC:A61K39/395, A61P11/00
[2008/22]
CPC:
C07K16/244 (EP,US); A61P11/00 (EP); A61K2039/505 (EP,US);
C07K2317/21 (EP,US)
Former IPC [2005/02]A61K39/395
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2005/02]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
TitleGerman:VERFAHREN ZUR BEHANDLUNG VON CHRONISCH-OBSTRUKTIVER LUNGENERKRANKUNG (COPD)[2005/02]
English:METHODS FOR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)[2005/02]
French:PROCEDES DE TRAITEMENT DE LA BRONCHO-PNEUMOPATHIE CHRONIQUE OBSTRUCTIVE (BPCO)[2005/02]
Entry into regional phase18.10.2004National basic fee paid 
18.10.2004Search fee paid 
18.10.2004Designation fee(s) paid 
18.10.2004Examination fee paid 
Examination procedure16.10.2003Request for preliminary examination filed
International Preliminary Examining Authority: US
18.10.2004Amendment by applicant (claims and/or description)
18.10.2004Examination requested  [2005/02]
07.07.2008Observations by third parties
09.09.2008Despatch of a communication from the examining division (Time limit: M04)
20.01.2009Application deemed to be withdrawn, date of legal effect  [2009/29]
26.02.2009Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2009/29]
Fees paidRenewal fee
14.03.2005Renewal fee patent year 03
09.03.2006Renewal fee patent year 04
14.03.2007Renewal fee patent year 05
14.03.2008Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
31.03.200907   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]US5677426  (FONG SHERMAN [US], et al) [A] 1-15 * example c *;
 [A]US5874080  (HEBERT CAROLINE A [US], et al) [A] 1-15 * example I *;
 [PX]  - BEEH KAI M ET AL, "Neutrophil chemotactic activity of sputum from patients with COPD: role of interleukin 8 and leukotriene B4.", CHEST APR 2003, (200304), vol. 123, no. 4, ISSN 0012-3692, pages 1240 - 1247, XP002477497 [PX] 1-15 * abstract *

DOI:   http://dx.doi.org/10.1378/chest.123.4.1240
 [T]  - HUANG S ET AL, "Fully humanized neutralizing antibodies to interleukin-8 (ABX-IL8) inhibit angiogenesis, tumor growth, and metastasis of human melanoma", AMERICAN JOURNAL OF PATHOLOGY, PHILADELPHIA, PA, US, (200207), vol. 161, no. 1, ISSN 0002-9440, pages 125 - 134, XP002359195 [T] 1-15 * the whole document *
International search[X]US6150584  (KUCHERLAPATI RAJU [US], et al)
other   - ABGENIX, INC., "Abgenix submits ind application to fda for abx-il8 in leading pulmonary disease", PRESS RELEASE, (20010920), page 1, XP003023161
    - YAMAMOTO C. ET AL., "Airway inflammation in copd assessed by sputum levels of interleukin-8", CHEST, (199708), vol. 112, no. 2, pages 505 - 510, XP003023162

DOI:   http://dx.doi.org/10.1378/chest.112.2.505
    - PESCI A. ET AL., "Inflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pulmonary disease", EUR RESPIR J, (1998), vol. 12, pages 380 - 386, XP003023163

DOI:   http://dx.doi.org/10.1183/09031936.98.12020380
    - YANG Y-D. ET AL., "FULLY HUMAN ANTI-INTERLEUKIN-8 MONOCLONAL ANTIBODIES: POTENTIAL THERAPEUTICS FORTHE TREATMENT OF INFLAMMATORY DISEASE STATES", J. LEUKOCYTE BIOL., (1999), vol. 66, no. 3, pages 401 - 410, XP001014326

DOI:   http://dx.doi.org/10.1002/jlb.66.3.401
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.